Navigation Links
Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
Date:1/9/2008

SAN DIEGO, Jan. 9 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced positive results from a single dose Phase 1a clinical trial of APD791 and the initiation of a multiple dose Phase 1b clinical trial to further evaluate the compound's safety, pharmacokinetics and pharmacodynamics. APD791 is Arena's internally discovered oral drug candidate intended for the treatment of arterial thrombosis.

The Phase 1a trial was a randomized, placebo-controlled, double-blind, single-ascending dose trial in 90 healthy male and female volunteers. Doses originally intended for study ranged from 1 mg to 160 mg, but due to excellent tolerability the maximum dose was increased to 320 mg. Doses were well tolerated, without any dose related adverse events, such that a maximum tolerated dose could not be defined despite achieving high concentrations in blood. APD791 was rapidly absorbed and exposures were generally related to dose. Terminal half-life (t1/2) of the parent plus active metabolites was also related to dose, and was approximately 11 hours at the higher doses. Dose dependent inhibition of serotonin-mediated amplification of platelet aggregation was demonstrated starting at the 1 mg dose, supporting APD791 preclinical data and establishing initial clinical validation of APD791's novel mechanism of action.

Based on the positive Phase 1a results, a Phase 1b trial was initiated. The Phase 1b trial is a randomized, placebo-controlled, double-blind, multiple-ascending dose trial in up to 50 healthy male and female volunteers between the ages of 19 and 45 years old. In addition to evaluating APD791's safety and tolerability profile, the trial will also evaluate the pharmacokinetics and pharmacodynamics of multip
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
4. Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
5. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
6. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
7. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
8. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
9. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
10. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
11. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- 3D Communications announced today that ... pharmaceutical companies communicate the value of their drugs ... newly expanded 3D Market Access and Reimbursement ... develop and deliver their "Value Story". It will also ... stakeholders earlier in the "innovation-to-market" timeline, and incorporate ...
(Date:5/6/2015)... SAN ANTONIO , May 6, 2015   GenSpera, ... "Injectable Cancer Compositions" has entered the national phase application process ... , Eurasia, Japan , China ... the United States . When awarded, the resulting patent ... property around its entire platform technology, including its lead drug ...
(Date:5/6/2015)... Advanced wound care - assess products, developments, ... future hold for the advanced wound care ... potential revenues to 2025, assessing data, trends, opportunities and ... provides 115 tables, charts, and graphs covering 12 distinct ... industry and the future market prospects. You will see ...
Breaking Medicine Technology:3D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 23D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 3GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6
(Date:5/7/2015)... 2015 When people think about protecting their ... their roofs than their basements. However, heavy rain falls also ... and basements. While flooding is an obvious problem in a ... unfinished areas dry to avoid a musty smell . ... Even small amounts of water can cause foundation damage, mold ...
(Date:5/7/2015)... Boston, MA (PRWEB) May 07, 2015 ... today the availability of its new free Alcohol ... is aimed at helping restaurant managers, professional bartenders, and ... earn their Alcohol Safety Certification. The material encompasses topics ... Upon completing the course, students can take the ServSafe ...
(Date:5/7/2015)... 07, 2015 “ Sky Hollywood Slots ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... casino game that focuses on slots. , According to the ... traveled to Sin City in 2014. But what’s even more ...
(Date:5/7/2015)... Made with love at the Belvoir ... Vegan, no preservatives, no sweeteners or artificial colors and ... will delight every palate. , Belvoir Fruit Farms launched ... has grown successfully ever since. This range of refreshing ... opportunities as cocktail mixers. , Belvoir is available in ...
(Date:5/6/2015)... A poker run to raise funds for the 2015 National ... run will start at the United Veterans Club, 1914 W. Capital ... poker run, participants will visit checkpoints, drawing a card at each ... the end of the run. The run will start at the ... Tavern, Fairmont American Legion, Hastings DAV post, Kearney American Legion and ...
Breaking Medicine News(10 mins):Health News:Spring Storms Bring Musty Smell Inside 2Health News:Spring Storms Bring Musty Smell Inside 3Health News:Dynamic Path Adds Alcohol Safety Exam Prep Module to Test Preparation Offerings 2Health News:A Social Casino Game that Focuses on Slots Was Featured on NewsWatch Television 2Health News:Updated Contacts: Poker Run Fundraiser to Benefit National Veterans Golden Age Games 2
... This release is available in French . ... two can be spontaneously aggressive and that boys can be ... of boys will continue to be hyper-aggressive until the age ... sub-group of aggressive children has a different makeup than non-aggressive ...
... Inexpensive, well-established lab tests may hold the key ... which is the focus of World Kidney Day, March ... results in kidney failure, cardiovascular disease and anemia. ... percent over the past 10 years. But kidney disease ...
... others involved in tumor development , , TUESDAY, March 10 (HealthDay ... lower risk of developing pancreatic cancer, a finding that might ... , The study, by researchers at the Dana-Farber Cancer ... type and the disease, which is diagnosed in about 40,000 ...
... to Mount For Strawberry Nutrition BenefitsWATSONVILLE, Calif., March 10 ... of super foods that improve health and ... on time. A new study published in the scientific ... in strawberries help lower "bad" cholesterol.The study, conducted by ...
... technology programs implemented in New York state are active ... and could serve as models for new federal initiatives, ... Medical College. , "Programs such as these could transform ... says senior author Dr. Rainu Kaushal, chief of the ...
... Fee Offers Easy, Practical Strategies to Sleep Like a ... More...NEW YORK, March 10 Founder and CEO of ... announced her latest crusade -- educating people about the ... how to achieve high-quality sleep through her revolutionary wellness ...
Cached Medicine News:Health News:Perinatal environment influences aggression in children 2Health News:Upcoming World Kidney Day Underscores Role of Low-Cost Lab Tests in Combating High-Cost Kidney Disease 2Health News:Study Links Blood Type and Pancreatic Cancer 2Health News:Spoonfuls of Strawberries Help the Cholesterol Go Down 2Health News:Spoonfuls of Strawberries Help the Cholesterol Go Down 3Health News:New York State health IT strategy may be model for the nation 2Health News:New York State health IT strategy may be model for the nation 3Health News:Tired? Sleepless? ... New Sleep Program 'Good Night, Sleep Right(TM)' Launches in April 2009 2
Produce clean 0.75 mm round hole without tissue tags. Serrated squeeze action handle....
... CSV- lOOOHGT instrument provides standardized glare testing. It ... test faces for the evaluation of glare disability. ... precisely calibrated to simulate two on-coming halogen car ... The glare level can be adjusted to simulate ...
Designed to determine the precise length of limbal incisions and proper alignment of closing sutures. Curved marking blade with 2 mm lines spaced 1 mm apart-measures up to 10 mm. Round knurled handle...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: